Phuturdex › Diseases › Adipose tissue neoplasm
Drugs in development · updated 30 October 2026
Adipose tissue neoplasm: drugs in development
As of 30 October 2026 there are 1 active clinical trials (recruiting or ongoing, phases I–III) on 4 drugs for adipose tissue neoplasm. 0 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| DoxorubicinAdriamycin, Doxorubincin | I–II | 1 | NCT06239272 |
| Ifosfamide | I–II | 1 | NCT06239272 |
| PazopanibVotrient® | I–II | 1 | NCT06239272 |
| SelinexorKPT-330, Xpovio® | I–II | 1 | NCT06239272 |
Sorted by most advanced phase and number of active trials.
All 4 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Liposarcoma 43 drugs
- Sarcoma 204 drugs
- Myxoid liposarcoma 15 drugs
- Leiomyosarcoma 36 drugs
- Synovial sarcoma 33 drugs
- Histiocytoma, Malignant Fibrous 19 drugs
- Non-small-cell lung carcinoma 726 drugs
- Colorectal neoplasm 534 drugs
- Osteosarcoma 101 drugs
- Hemangiosarcoma 58 drugs
- Fibrosarcoma 8 drugs
- Perivascular epithelioid cell neoplasm 5 drugs
Broader categories
- Female urogenital disease 11 drugs
- Female urogenital diseases and pregnancy complications 3 drugs
- Urogenital Diseases 16 drugs
- Male urogenital disease 19 drugs
- Neoplasm 671 drugs
- Nervous System Diseases 39 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D018205 “Neoplasms, Adipose Tissue”.